Write in a clean editor, then format for Frontiers in Lupus in one click — DocuGuru applies the official Frontiers template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Frontiers in Lupus is a peer-reviewed journal published by Frontiers, covering Systemic Lupus Erythematosus Research, Pregnancy and Medication Impact, Reproductive System and Pregnancy. Over its lifetime it has published 57 papers, which have received 127 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Frontiers in Lupus. 2023;12(3):45–58.
Formats any DOI in Frontiers in Lupus style. No sign-up. |
| Publishes research in | Systemic Lupus Erythematosus Research Pregnancy and Medication Impact Reproductive System and Pregnancy Atherosclerosis and Cardiovascular Diseases Rheumatoid Arthritis Research and Therapies |
| ISSN | 2813-6934 |
| Citation impact (2-yr) | 2.08 |
| h-index | 5 |
| i10-index | 2 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | United States Department of Veterans Affairs |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
An in-depth literature review of up to 2023 reveals 330 risk loci found by genetic association at p ≤ 5 × 10 −8 , with systemic lupus erythematosus (SLE) in at least one study of 160 pertinent publications. There are 225 loci found in East Asian (EAS), 106 in European (EU), 11 in African-American (AA),…
Background/Purpose Cutaneous lupus erythematosus (CLE) affects up to 70% of patients with systemic lupus erythematosus (SLE), and type I interferons (IFNs) are important promoters of SLE and CLE. Our previous work identified IFN-kappa (IFN-κ), a keratinocyte-produced type I IFN, as upregulated in non-lesional and lesional lupus skin and as a critical regulator for enhanced UVB-mediated…
Systemic lupus erythematosus (SLE, lupus) is a chronic autoimmune disease characterised by a heterogeneous clinical presentation and complex underlying immunologic dysfunction. This poses a significant challenge to the accurate assessment of disease activity, which is central to both clinical management and research in SLE. This review aims to describe common barriers to accurately measuring disease…
Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune condition with complex causes involving genetic and environmental factors. While genome-wide association studies (GWASs) have identified genetic loci associated with SLE, the functional genomic elements responsible for disease development remain largely unknown. Mendelian Randomization (MR) is an instrumental variable approach to causal inference based on data…
Lupus nephritis (LN) is a common and serious manifestation of systemic lupus erythematosus and is a major cause of mortality and morbidity. The current standard-of-care treatment for LN include conventional immunosuppressive treatments such as mycophenolate mofetil, cyclophosphamide, or azathioprine, combined with glucocorticoids. However, this treatment approach has several unmet needs, such as achieving only modest…
Frontiers in Cellular and Infection Microbiology
Frontiers in Chemical Engineering
Frontiers in Clinical Diabetes and Healthcare
Frontiers in Communications and Networks
Frontiers in Conservation Science
Frontiers in Detector Science and Technology
Biotechnology for Biofuels and Bioproducts
BMC Cancer
